Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 46

Sort by

Sort Order Select

Journal Articles

Prognostic Prediction with Static-Dynamic Clinical and Pathological Parameters By Machine Learning Algorithm in Acute Lymphoblastic Leukemia

Bor-Sheng Ko, MD PhD, Yu-Fen Wang, MS, Jeng-Lin Li, BS, Hsin-An Hou, Wen-Chien Chou, MD PhD, Hwei-Fang Tien, MD, PhD, Ting-Yu Chang, M.S., Chi-Chun Lee, PhD

Blood (2020) 136 (Supplement 1): 1.

https://doi.org/10.1182/blood-2020-139766

Published: 2020

Journal Articles

Accurate Prediction of Gene Mutations with Flow Cytometry Immune-Phenotyping By Machine Learning Algorithm

Bor-Sheng Ko, MD PhD, Yu-Fen Wang, MS, Jeng-Lin Li, BS, Hsin-An Hou, Wen-Chien Chou, MD PhD, Hwei-Fang Tien, MD, PhD, Ting-Yu Chang, M.S., Chi-Chun Lee, PhD

Blood (2020) 136 (Supplement 1): 7–8.

https://doi.org/10.1182/blood-2020-139623

Published: 2020

Journal Articles

Minimal Residual Disease Monitoring By Next-Generation Sequencing in Patients with Acute Myeloid Leukemia: MRD Positivity after First Consolidation Chemotherapy Can Better Predict Clinical Outcomes Than That after Induction Chemotherapy

Cheng-Hong Tsai, MD MSc, Jih-Luh Tang, MD, PhD, Feng-Ming Tien, MD, M.Sc, Yuan-Yeh Kuo, PhD, Chien-Chin Lin, MD, Mei-Hsuan Tseng, M.Sc., Yen-Ling Peng, M.Sc., Ming-Chih Liu, Chia-Wen Liu, Ming Yao, Liang-In Lin, PhD, Wen-Chien Chou, MD, PhD, Chien-Yu Chen, PhD, Hsin-An Hou, Hwei-Fang Tien, MD, PhD

Blood (2019) 134 (Supplement_1): 2698.

https://doi.org/10.1182/blood-2019-126870

Published: 2019

Journal Articles

The Clinical Association and Prognostic Impact of IL1RAP Expression in Patients with De Novo Acute Myeloid Leukemia

Chao-Hung Wei, MD, Cheng-Hong Tsai, MD, M.Sc., Jih-Luh Tang, MD, PhD, Yuan-Yeh Kuo, PhD, Feng-Ming Tien, MD, M.Sc, Chien-Chin Lin, MD, Mei-Hsuan Tseng, M.Sc., Yen-Ling Peng, Ming-Chih Liu, Chia-Wen Liu, Ming Yao, MD, Liang-In Lin, PhD, Wen-Chien Chou, MD, PhD, Chien-Yu Chen, PhD, Hsin-An Hou, Hwei-Fang Tien, MD, PhD

Blood (2019) 134 (Supplement_1): 2705.

https://doi.org/10.1182/blood-2019-124657

Published: 2019

Journal Articles

Risk of Second Primary Malignancy in Multiple Myeloma in the Novel Therapy Era from 15 Years of Cancer Registry

Hsin-An Hou, Yanfang Liu, MD MPH, Hong Qiu, MD PhD, Hwei-Fang Tien, MD, PhD, Chao-Hsiun Tang

Blood (2019) 134 (Supplement_1): 1878.

https://doi.org/10.1182/blood-2019-124296

Published: 2019

Journal Articles

Automatic Bone Marrow Cell Identification and Classification By Deep Neural Network

Ta-Chuan Yu, MD, Wen-Chien Chou, MD, PhD, Chao-Yuan Yeh, MD, Cheng-Kun Yang, Sheng-Chuan Huang, MD, Feng Ming Tien, MD, Chi-Yuan Yao, MD, Chieh-Lung Cheng, MD, Ming-Kai Chuang, MD, Hwei-Fang Tien, MD, PhD, Qun-Yi Zhang, Wei-Han Hsu, Sheng-Cheih Chou

Blood (2019) 134 (Supplement_1): 2084.

https://doi.org/10.1182/blood-2019-125322

Published: 2019

Journal Articles

Use of Machine Learning in 2074 Cases of Acute Myeloid Leukemia for Genetic Risk Profiling

Shaun Fleming, MBBS,, Cheng-Hong Tsai, MD MSc, Hartmut Döhner, MD, Konstanze Döhner, Elli Papaemmanuil, PhD, Hwei-Fang Tien, MD, PhD, John Reynolds, PhD, Andrew H. Wei, PhD FRACP, FRCPA, MBBS, Hsin-An Hou

Blood (2019) 134 (Supplement_1): 1392.

https://doi.org/10.1182/blood-2019-128243

Published: 2019

Journal Articles

Anti-Viral Prophylaxis for Hepatitis B Virus Is Associated with Improved Outcome in Patients with Diffuse Large B Cell Lymphoma in Taiwan - a Population-Based Study between 2011 and 2015

Huai-Hsuan Huang, Fei-Yuan Hsiao, PhD Associate Professor, Ho-Min Chen, M.S., Chen-Yu Wang, PhD, Hwei-Fang Tien, MD, PhD, Bor-Sheng Ko, MD PhD

Blood (2019) 134 (Supplement_1): 4765.

https://doi.org/10.1182/blood-2019-127972

Published: 2019

Journal Articles

Hepatitis B Surface Antigen Positivity Is an Independent Unfavorable Prognostic Factor for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma Treated with Standard Chemoimmunotherapy

Chieh-Lung Cheng, MD, Erin Huang, Ming-Kai Chuang, MD, Wen-Chien Chou, MD, PhD, Hwei-Fang Tien, MD, PhD

Blood (2018) 132 (Supplement 1): 4235.

https://doi.org/10.1182/blood-2018-99-114982

Published: 2018

Journal Articles

A Leukemic Stem Cell Signature-Based Scoring System for Predicting Prognosis in Myelodysplastic Syndrome Patients

Yu-Hung Wang, MD, Chien-Chin Lin, MD, Chi-Yuan Yao, MD, Cheng-Hong Tsai, MD, M.Sc., Hsin-An Hou, MD PhD, Wen-Chien Chou, MD, PhD, Hwei-Fang Tien, MD, PhD

Blood (2018) 132 (Supplement 1): 1810.

https://doi.org/10.1182/blood-2018-99-110768

Published: 2018

Journal Articles

Re-Examination of 2017 ELN Risk Classification By a Cohort of 739 De Novo aml Patients in Taiwan: Co-Occurring Poor-Risk Mutations May Further Predict Outcome in FLT3 -ITD Patients

Blood (2018) 132 (Supplement 1): 3977.

https://doi.org/10.1182/blood-2018-99-114315

Published: 2018

Journal Articles

The Clinical and Biological Implications of Early Clearance of Peripheral Blood Blasts after Induction Chemotherapy in Acute Myeloid Leukemia

Ming-Kai Chuang, MD, Yu-Chiao Chiu, PhD, Hsin-An Hou, MD PhD, Wen-Chien Chou, MD, PhD, Jih-Luh Tang, MD, Hwei-Fang Tien, MD, PhD

Blood (2018) 132 (Supplement 1): 3991.

https://doi.org/10.1182/blood-2018-99-114071

Published: 2018

Journal Articles

Metabolic Alterations May Contribute to Cabozantinib Resistance in Acute Myeloid Leukemia Cells with FLT3 -ITD

Fang-Yu Lo, Kit Man Ng, MS, Wen-Chun Chen, MS, Chung-Yi Hu, PhD, Hsin-An Hou, MD PhD, Cheng-Hong Tsai, MD, M.Sc., Da-Liang Ou, PhD, Hwei-Fang Tien, MD, PhD, Liang-In Lin, PhD

Blood (2018) 132 (Supplement 1): 2785.

https://doi.org/10.1182/blood-2018-99-118322

Published: 2018

Journal Articles

Discrepant Mutational Composition between Myeloid Sarcoma and Bone Marrow Leukemia Revealed through Targeted Next Generation Sequencing

Sze Hwei Lee, MD, Tai-Chung Huang, MD PhD, Yuan Chang-Tsu, MD, Yuan-Yeh Kuo, PhD, Rung-Jing Chiou, Yi-Kuang Chuang, Hwei-Fang Tien, MD, PhD, Jih-Luh Tang, MD

Blood (2018) 132 (Supplement 1): 1395.

https://doi.org/10.1182/blood-2018-99-116637

Published: 2018

Journal Articles

Relapse and Mortality Prediction of Acute Myeloid Leukemia Patients Using Deep Bidirectional Long Short-Term Memory-Deep Neural Network Architecture

Bor-Sheng Ko, MD PhD, Yu-Fen Wang, MS, Chih-Chuan Lu, B.S., Jeng-Lin Li, BS, Chi-Chun Lee, PhD, Jih-Luh Tang, MD, Hwei-Fang Tien, MD, PhD

Blood (2018) 132 (Supplement 1): 2811.

https://doi.org/10.1182/blood-2018-99-115778

Published: 2018

Journal Articles

SNP-Array Genome Wide Association Study Meta-Analysis Identifies Innate Immune Susceptibility Loci Associated with Non-Del(5q) Myelodysplastic Syndromes Predisposition

Blood (2018) 132 (Supplement 1): 107.

https://doi.org/10.1182/blood-2018-99-118747

Published: 2018

Journal Articles

Pyrvinium Pamoate Overcomes Cabozantinib-Resistance of FLT3 -ITD AML Cells through Modulating the Mitochondria Functions and Signaling Pathways

Yu-Hsuan Fu, BS, Wen-Hui Lu, MS, Pei-Qi Lan, MS, Chung-Yi Hu, PhD, Chien-Yuan Chen, MD, PhD, Da-Liang Ou, PhD, Hwei-Fang Tien, MD, PhD, Liang-In Lin, PhD

Blood (2018) 132 (Supplement 1): 4683.

https://doi.org/10.1182/blood-2018-99-118476

Published: 2018

Journal Articles

The Clinical and Biological Implications of Aberrant Alternative Splicing in Patients with De Novo, Non-M3 Acute Myeloid Leukemia

Chiu Po-Ju, MD, Yi-Tsung Yang, Yu-Chiao Chiu, PhD, Hsin-An Hou, MD, PhD, Jih-Luh Tang, MD,PhD, Ming Yao, MD, Chi-Cheng Li, MD, Shang-Yi Huang, MD, PhD, Bor-Sheng Ko, MD, PhD, Szu-Chun Hsu, MD, Chien-Ting Lin, MD, Shang-Ju Wu, MD, PhD, Woei Tsai, MD, PhD, Yidong Chen, PhD, Wen-Chien Chou, MD, PhD, Hwei-Fang Tien, MD, PhD

Blood (2017) 130 (Supplement 1): 1382.

https://doi.org/10.1182/blood.V130.Suppl_1.1382.1382

Published: 2017

Journal Articles

The Clinical Implication and Prognostic Impact of Dynamic Molecular Evolution in Acute Myeloid Leukemia

Jui-Che Chen, MD, Cheng-Hong Tsai, MD, M.Sc., Jih-Luh Tang, MD,PhD, Yuan-Yeh Kuo, PhD, Chien-Chin Lin, MD, Mei-Hsuan Tseng, M.Sc., Ming Yao, MD, Chi-Cheng Li, MD, Shang-Yi Huang, MD, PhD, Bor-Sheng Ko, MD, PhD, Szu-Chun Hsu, MD, Chien-Ting Lin, MD, Shang-Ju Wu, MD, PhD, Chien-Yuan Chen, MD, PhD, Woei Tsai, MD, PhD, Wen-Chien Chou, MD, PhD, Hsin-An Hou, MD, PhD, Hwei-Fang Tien, MD, PhD

Blood (2017) 130 (Supplement 1): 1300.

https://doi.org/10.1182/blood.V130.Suppl_1.1300.1300

Published: 2017

Journal Articles

An Artificial Intelligence Approach in Classifying Acute Myeloid Leukemia and Myelodysplastic Syndrome for Minimal Residual Disease Detection with Post Induction Prognosis Analysis Using Flow Cytometry

Bor-Sheng Ko, MD, PhD, Chi-Cheng Li, MD, Yu-Fen Wang, MS, Jeng-Lin Li, BS, Hsin-An Hou, MD, PhD, Pei-Fang Weng, BS, Hwei-Fang Tien, MD, PhD, Chi-Chun Lee, PhD, Jih-Luh Tang, MD,PhD

Blood (2017) 130 (Supplement 1): 1403.

https://doi.org/10.1182/blood.V130.Suppl_1.1403.1403

Published: 2017

NARROW

Prognostic Prediction with Static-Dynamic Clinical and Pathological Parameters By Machine Learning Algorithm in Acute Lymphoblastic Leukemia

Accurate Prediction of Gene Mutations with Flow Cytometry Immune-Phenotyping By Machine Learning Algorithm

Minimal Residual Disease Monitoring By Next-Generation Sequencing in Patients with Acute Myeloid Leukemia: MRD Positivity after First Consolidation Chemotherapy Can Better Predict Clinical Outcomes Than That after Induction Chemotherapy

The Clinical Association and Prognostic Impact of IL1RAP Expression in Patients with De Novo Acute Myeloid Leukemia

Risk of Second Primary Malignancy in Multiple Myeloma in the Novel Therapy Era from 15 Years of Cancer Registry

Automatic Bone Marrow Cell Identification and Classification By Deep Neural Network

Use of Machine Learning in 2074 Cases of Acute Myeloid Leukemia for Genetic Risk Profiling

Anti-Viral Prophylaxis for Hepatitis B Virus Is Associated with Improved Outcome in Patients with Diffuse Large B Cell Lymphoma in Taiwan - a Population-Based Study between 2011 and 2015

Hepatitis B Surface Antigen Positivity Is an Independent Unfavorable Prognostic Factor for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma Treated with Standard Chemoimmunotherapy

A Leukemic Stem Cell Signature-Based Scoring System for Predicting Prognosis in Myelodysplastic Syndrome Patients

Re-Examination of 2017 ELN Risk Classification By a Cohort of 739 De Novo aml Patients in Taiwan: Co-Occurring Poor-Risk Mutations May Further Predict Outcome in FLT3 -ITD Patients

The Clinical and Biological Implications of Early Clearance of Peripheral Blood Blasts after Induction Chemotherapy in Acute Myeloid Leukemia

Metabolic Alterations May Contribute to Cabozantinib Resistance in Acute Myeloid Leukemia Cells with FLT3 -ITD

Discrepant Mutational Composition between Myeloid Sarcoma and Bone Marrow Leukemia Revealed through Targeted Next Generation Sequencing

Relapse and Mortality Prediction of Acute Myeloid Leukemia Patients Using Deep Bidirectional Long Short-Term Memory-Deep Neural Network Architecture

SNP-Array Genome Wide Association Study Meta-Analysis Identifies Innate Immune Susceptibility Loci Associated with Non-Del(5q) Myelodysplastic Syndromes Predisposition

Pyrvinium Pamoate Overcomes Cabozantinib-Resistance of FLT3 -ITD AML Cells through Modulating the Mitochondria Functions and Signaling Pathways

The Clinical and Biological Implications of Aberrant Alternative Splicing in Patients with De Novo, Non-M3 Acute Myeloid Leukemia

The Clinical Implication and Prognostic Impact of Dynamic Molecular Evolution in Acute Myeloid Leukemia

An Artificial Intelligence Approach in Classifying Acute Myeloid Leukemia and Myelodysplastic Syndrome for Minimal Residual Disease Detection with Post Induction Prognosis Analysis Using Flow Cytometry

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only